Source Facts: Financial Supervisory Service DART / 2024-12-26
Disclosure Type: Sales and Supply Contract (Amendment)
💡 3-Second Summary
Hanwha Aerospace has extended the confidentiality-based disclosure postponement period for a supply contract signed in September 2024, moving the deadline to April 30, 2025.
📊 1. Key Disclosure Details & Major Figures
- Contract Category: Goods Supply
- Contract Amount & Ratio: Undisclosed due to confidentiality (confirmed to exceed 2.5% of 2023 consolidated revenue of KRW 9,359,005,981,309).
- Counterparty & Region: Undisclosed (business confidentiality).
- Contract Date / Start Date: September 04, 2024
- Reason for Postponement: Business confidentiality
- Postponement Deadline Amendment: December 31, 2024 → April 30, 2025 (Extended)
- Note: Contract title, value, counterparty, region, and key terms remain fully undisclosed and will be re-disclosed once confidentiality conditions expire.
📈 2. Expert Perspective: What This Disclosure Means for Investors
This disclosure notifies investors that Hanwha Aerospace has extended the disclosure deferral window for a supply contract entered into on September 4, 2024. The deadline for keeping contract specifics confidential has been moved from December 31, 2024, to April 30, 2025.
While exact terms remain withheld under regulatory confidentiality provisions, the filing notes that the contract value exceeds 2.5% of the company’s 2023 annual revenue (approx. KRW 9.36T). Investors can observe that detailed disclosures regarding contract size and counterparty are now deferred until April 30, 2025, or when confidentiality obligations lapse.
📝 Editor’s Comment (by K-STOCK Editor)
Hanwha Aerospace has deferred the disclosure of details for a major supply contract signed in September 2024 until April 30, 2025. This step maintains standard regulatory non-disclosure protections for commercial secrets.
Moving forward, the primary checkpoint for market participants is tracking whether the confidentiality requirement lapses by the updated April 30, 2025 deadline, triggering a follow-up filing. Verifying the finalized contract value and counterparty upon official re-disclosure will serve as the main evaluation point.
📢 Disclaimer & Source Notice
Source: This content was structured and newly compiled based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
